Clinical Trial Update: Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.

View source ↗

Summary

A completed clinical trial examining the expression levels of Progesterone Induced Blocking Factor in endometrial cancer cells.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Kayseri Education and Research Hospital | Conditions: Progesterone Induced Blocking Factor in Endometrial Cancer | Status: COMPLETED